Summary of TC for patients with multiple sclerosis (study purpose, study design, place of study, sample size (attribution%), age of patients, disease duration, and stage in disease progression.
DMD, disease-modifying drug; EDSS, expanded disability status scale; IT, immunotherapy; MS, multiple sclerosis; N, number of patients; OTC, over-the-counter; PRN, pro re nata. (XLSX)
